2016
DOI: 10.1200/jco.2016.34.15_suppl.e18553
|View full text |Cite
|
Sign up to set email alerts
|

Effect of adequate hypomethylating agent (HMA) therapy on adverse prognostic factors in very elderly patients (>75 yrs) with myelodysplastic syndrome (MDS).

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles